Literature DB >> 3388033

Inactivation of the retinoblastoma susceptibility gene in human breast cancers.

E Y Lee1, H To, J Y Shew, R Bookstein, P Scully, W H Lee.   

Abstract

Mutational inactivation of the retinoblastoma susceptibility (RB) gene, a recessive cancer gene, has been implicated in the genesis of retinoblastoma and certain other human neoplasms. This gene is now shown to be inactivated in two of nine human breast cancer cell lines examined. The RB gene of one cell line had a homozygous internal duplication of a 5-kilobase region containing exons 5 and 6. The RB messenger RNA transcript was correspondingly lengthened, and its translation was probably terminated prematurely due to a shifted reading frame. The other cell line had a homozygous deletion of the RB gene that removed the entire gene beyond exon 2. The RB gene product, pp110RB, was not detectable in either cell line by immuno-precipitation with specific antibodies. These findings are significant in relation to proposed genetic mechanisms of breast cancer formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3388033     DOI: 10.1126/science.3388033

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  151 in total

1.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Genes involved in breast cancer progression: analysis of global changes in gene expression or retroviral tagging?

Authors:  Emmett V Schmidt
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 3.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

4.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

5.  The retinoblastoma gene product regulates Sp1-mediated transcription.

Authors:  S J Kim; U S Onwuta; Y I Lee; R Li; M R Botchan; P D Robbins
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

6.  Loss of heterozygosity on chromosome 1q in human breast cancer.

Authors:  L C Chen; C Dollbaum; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

8.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Authors:  Y Suzuki; G Tamura; C Maesawa; T Fujioka; T Kubo; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.

Authors:  Joseph A Caruso; Rody Campana; Caimiao Wei; Chun-Hui Su; Amanda M Hanks; William G Bornmann; Khandan Keyomarsi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.